This page shows the latest Anavex news and features for those working in and with pharma, biotech and healthcare.
But the biotech thinks that the broad activity of Anavex 2-73 and biomarker-driven clinical trials elevate its chances of success. ... It is planning to use a similar process and trial design for a phase II study of Anavex 2-73 in Parkinson’s disease.
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...